These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31980023)

  • 1. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy.
    Zhong X; Zhang H; Zhu Y; Liang Y; Yuan Z; Li J; Li J; Li X; Jia Y; He T; Zhu J; Sun Y; Jiang W; Zhang H; Wang C; Ke Z
    Mol Cancer; 2020 Jan; 19(1):15. PubMed ID: 31980023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of circulating tumor cells in immunotherapy.
    Rzhevskiy A; Kapitannikova A; Malinina P; Volovetsky A; Aboulkheyr Es H; Kulasinghe A; Thiery JP; Maslennikova A; Zvyagin AV; Ebrahimi Warkiani M
    Theranostics; 2021; 11(16):8057-8075. PubMed ID: 34335980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling circulating tumour cells and other biomarkers of invasive cancers.
    Poudineh M; Sargent EH; Pantel K; Kelley SO
    Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology and clinical potential of circulating tumor cells.
    Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
    Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.
    Agarwal A; Balic M; El-Ashry D; Cote RJ
    Cancer J; 2018; 24(2):70-77. PubMed ID: 29601333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
    Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells: biology and clinical significance.
    Lin D; Shen L; Luo M; Zhang K; Li J; Yang Q; Zhu F; Zhou D; Zheng S; Chen Y; Zhou J
    Signal Transduct Target Ther; 2021 Nov; 6(1):404. PubMed ID: 34803167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
    Chalfin HJ; Pramparo T; Mortazavi A; Niglio SA; Schonhoft JD; Jendrisak A; Chu YL; Richardson R; Krupa R; Anderson AKL; Wang Y; Dittamore R; Pal SK; Lara PN; Stein MN; Quinn DI; Steinberg SM; Cordes LM; Ley L; Mallek M; Sierra Ortiz O; Costello R; Cadena J; Diaz C; Gulley JL; Dahut WL; Streicher H; Wright JJ; Trepel JB; Bottaro DP; Apolo AB
    Clin Cancer Res; 2021 Mar; 27(5):1391-1398. PubMed ID: 33262136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
    Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients.
    Ortiz-Otero N; Marshall JR; Lash B; King MR
    BMC Cancer; 2020 Sep; 20(1):873. PubMed ID: 32917154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents.
    Garrido-Navas C; de Miguel-Perez D; Exposito-Hernandez J; Bayarri C; Amezcua V; Ortigosa A; Valdivia J; Guerrero R; Garcia Puche JL; Lorente JA; Serrano MJ
    Cells; 2019 Nov; 8(11):. PubMed ID: 31684193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives.
    Wu T; Cheng B; Fu L
    Mol Pharmacol; 2017 Sep; 92(3):232-239. PubMed ID: 28356334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Matrigel Transwell Invasion Assay to Detect and Enumerate Circulating Tumor Cells.
    Liu X; Wu X
    Methods Mol Biol; 2017; 1634():277-282. PubMed ID: 28819859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technologies for Viable Circulating Tumor Cell Isolation.
    Tretyakova MS; Menyailo ME; Schegoleva AA; Bokova UA; Larionova IV; Denisov EV
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.